Genelux Corporation
Status: Publicly traded
Direct answer
Genelux Corporation is publicly traded on NASDAQ under the ticker GNLX.
Genelux Corporation is a clinical-stage biopharmaceutical company focused on pioneering advanced oncolytic viral immunotherapies for patients confronting aggressive and/or hard-to-treat solid tumor malignancies. Its leading experimental drug, Olvi-Vec, is a proprietary, engineered vaccinia virus strain being developed to address ovarian cancer and non-small cell lung cancer. The company is also advancing V2ACT...
Can you invest in Genelux Corporation?
Yes. Genelux Corporation is publicly traded on NASDAQ under the ticker GNLX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Genelux Corporation
Detailed equity research is provided by MarketSnap.